Emodin is a novel phosphatidylethanolamine anabolism inhibitor that reprograms lipid metabolism to overcome 5-fluorouracil resistance in colorectal cancer.

Author: Yanyan CHEN ¹ ; Yanchen LIU ¹ ; Zhicheng GONG ¹ ; Zhaohui HUANG ¹
Author Information

1. Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214062, China.
Publication Type:Journal Article
From: Journal of Pharmaceutical Analysis 2025;15(10):101343-101343
CountryChina
Language:English
Abstract: Image 1.